ESC 365 - Gene therapy: the future of personalised atrial fibrillation management?

EHRA Premium Access

Gene therapy: the future of personalised atrial fibrillation management?

Session: Gene and molecular therapies for cardiac arrhythmias and SCD

Topic: Molecular biology / genetics

Speaker: Associate Professor D. Thomas (Heidelberg, DE)

Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Presentation

Add to my library

About the speaker

Associate Professor Dierk Thomas

University Hospital Heidelberg, Heidelberg (Germany)

4 presentations

0 follower

3 more presentations in this session

Gene therapy calcium handling dysfunction in heart failure.

Speaker: Professor O. Mueller (Kiel, DE)

Gene therapy of inherited arrhythmias.

Speaker: Doctor C. Napolitano (Pavia, IT)

Molecular strategies to treat post MI arrhythmias.

Speaker: Professor L. Gepstein (Haifa, IL)

Access the full session

Gene and molecular therapies for cardiac arrhythmias and SCD

Speakers: Associate Professor D. Thomas, Professor O. Mueller, Doctor C. Napolitano, Professor L. Gepstein

About the event

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources